{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:05:14Z","timestamp":1760148314521,"version":"build-2065373602"},"reference-count":24,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation (SNSF)","doi-asserted-by":"publisher","award":["406440_131268","320030_160283"],"award-info":[{"award-number":["406440_131268","320030_160283"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Helmut Horten Foundation","award":["406440_131268","320030_160283"],"award-info":[{"award-number":["406440_131268","320030_160283"]}]},{"name":"ETH Zurich","award":["406440_131268","320030_160283"],"award-info":[{"award-number":["406440_131268","320030_160283"]}]},{"name":"Uniscientia Foundation","award":["406440_131268","320030_160283"],"award-info":[{"award-number":["406440_131268","320030_160283"]}]},{"name":"Vontobel Foundation","award":["406440_131268","320030_160283"],"award-info":[{"award-number":["406440_131268","320030_160283"]}]},{"name":"private foundation located in Switzerland","award":["406440_131268","320030_160283"],"award-info":[{"award-number":["406440_131268","320030_160283"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>In the past, our research group was able to successfully remove circulating tumor cells with magnetic nanoparticles. While these cancer cells are typically present in low numbers, we hypothesized that magnetic nanoparticles, besides catching single cells, are also capable of eliminating a large number of tumor cells from the blood ex vivo. This approach was tested in a small pilot study in blood samples of patients suffering from chronic lymphocytic leukemia (CLL), a mature B-cell neoplasm. Cluster of differentiation (CD) 52 is a ubiquitously expressed surface antigen on mature lymphocytes. Alemtuzumab (MabCampath\u00ae) is a humanized, IgG1\u03ba, monoclonal antibody directed against CD52, which was formerly clinically approved for treating chronic lymphocytic leukemia (CLL) and therefore regarded as an ideal candidate for further tests to develop new treatment options. Alemtuzumab was bound onto carbon-coated cobalt nanoparticles. The particles were added to blood samples of CLL patients and finally removed, ideally with bound B lymphocytes, using a magnetic column. Flow cytometry quantified lymphocyte counts before, after the first, and after the second flow across the column. A mixed effects analysis was performed to evaluate removal efficiency. p &lt; 0.05 was defined as significant. In the first patient cohort (n = 10), using a fixed nanoparticle concentration, CD19-positive B lymphocytes were reduced by 38% and by 53% after the first and the second purification steps (p = 0.002 and p = 0.005), respectively. In a second patient cohort (n = 11), the nanoparticle concentration was increased, and CD19-positive B lymphocytes were reduced by 44% (p &lt; 0.001) with no further removal after the second purification step. In patients with a high lymphocyte count (&gt;20 G\/L), an improved efficiency of approximately 20% was observed using higher nanoparticle concentrations. A 40 to 50% reduction of B lymphocyte count using alemtuzumab-coupled carbon-coated cobalt nanoparticles is feasible, also in patients with a high lymphocyte count. A second purification step did not further increase removal. This proof-of-concept study demonstrates that such particles allow for the targeted extraction of larger amounts of cellular blood components and might offer new treatment options in the far future.<\/jats:p>","DOI":"10.3390\/ijms24087523","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T03:25:11Z","timestamp":1681961111000},"page":"7523","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Targeted Large-Volume Lymphocyte Removal Using Magnetic Nanoparticles in Blood Samples of Patients with Chronic Lymphocytic Leukemia: A Proof-of-Concept Study"],"prefix":"10.3390","volume":"24","author":[{"given":"Stefanie","family":"Janker","sequence":"first","affiliation":[{"name":"Institute of Anesthesiology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland"},{"name":"Institute of Physiology, University of Zurich, 8057 Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Doswald","sequence":"additional","affiliation":[{"name":"Institute for Chemical and Bioengineering, ETH, 8093 Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman R.","family":"Schimmer","sequence":"additional","affiliation":[{"name":"Institute of Physiology, University of Zurich, 8057 Zurich, Switzerland"},{"name":"Department of Medical Oncology and Hematology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urs","family":"Schanz","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Hematology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendelin J.","family":"Stark","sequence":"additional","affiliation":[{"name":"Institute for Chemical and Bioengineering, ETH, 8093 Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4288-7124","authenticated-orcid":false,"given":"Martin","family":"Schl\u00e4pfer","sequence":"additional","affiliation":[{"name":"Institute of Anesthesiology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland"},{"name":"Institute of Physiology, University of Zurich, 8057 Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0648-6115","authenticated-orcid":false,"given":"Beatrice","family":"Beck-Schimmer","sequence":"additional","affiliation":[{"name":"Institute of Anesthesiology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland"},{"name":"Institute of Physiology, University of Zurich, 8057 Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"ref_2","first-page":"361","article-title":"Current concepts in diagnosis and treatment of chronic lymphocytic leukemia","volume":"19","author":"Hus","year":"2015","journal-title":"Contemp. Oncol. (Pozn.)"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11912-015-0454-0","article-title":"Integrating Oncogeriatric Tools into the Management of Chronic Lymphocytic Leukemia: Current State of the Art and Challenges for the Future","volume":"17","author":"Merli","year":"2015","journal-title":"Curr. Oncol. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1182\/asheducation-2013.1.158","article-title":"Treatment of older patients with chronic lymphocytic leukemia: Key questions and current answers","volume":"2013","author":"Shanafelt","year":"2013","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Doswald, S., Herzog, A.F., Zeltner, M., Zabel, A., Pregernig, A., Schl\u00e4pfer, M., Siebenh\u00fcner, A., Stark, W.J., and Beck-Schimmer, B. (2022). Removal of Circulating Tumor Cells from Blood Samples of Cancer Patients Using Highly Magnetic Nanoparticles: A Translational Research Project. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14071397"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1038\/sj.onc.1210380","article-title":"Alemtuzumab (Campath-1H) in the treatment of chronic lymphocytic leukemia","volume":"26","author":"Alinari","year":"2007","journal-title":"Oncogene"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the Use of Therapeutic Apheresis in Clinical Practice\u2014Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J. Clin. Apher."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e10143","DOI":"10.1002\/btm2.10143","article-title":"Nanoparticles in the clinic: An update","volume":"4","author":"Anselmo","year":"2019","journal-title":"Bioeng. Transl. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/smll.201000438","article-title":"Blood Purification Using Functionalized Core\/Shell Nanomagnets","volume":"6","author":"Herrmann","year":"2010","journal-title":"Small"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.biomaterials.2018.10.029","article-title":"Engineered nanoparticles disguised as macrophages for trapping lipopolysaccharide and preventing endotoxemia","volume":"189","author":"Shen","year":"2019","journal-title":"Biomaterials"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/adhm.201200358","article-title":"Endotoxin removal by magnetic separation-based blood purification","volume":"2","author":"Herrmann","year":"2013","journal-title":"Adv. Healthc. Mater."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"8829","DOI":"10.1021\/la904589p","article-title":"Binding of functionalized paramagnetic nanoparticles to bacterial lipopolysaccharides and DNA","volume":"26","author":"Bromberg","year":"2010","journal-title":"Langmuir"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"8718","DOI":"10.1039\/c3nr02468g","article-title":"Nanomagnet-based removal of lead and digoxin from living rats","volume":"5","author":"Herrmann","year":"2013","journal-title":"Nanoscale"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Ooi, A.T. (2022). Single-Cell Protein Analysis Methods and Protocols, Methods in Molecular Biology; Humana Press.","DOI":"10.1007\/978-1-0716-1771-7"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/trf.14329","article-title":"The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis: A propensity score-matched study","volume":"58","author":"Choi","year":"2018","journal-title":"Transfusion"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.2147\/IJGM.S321787","article-title":"Leukapheresis and Hyperleukocytosis, Past and Future","volume":"14","author":"Zhang","year":"2021","journal-title":"Int. J. Gen. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/blood.V38.3.299.299","article-title":"Effect of high concentrations of leukocytes on whole blood viscosity","volume":"38","author":"Steinberg","year":"1971","journal-title":"Blood"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3324\/haematol.2010.031377","article-title":"Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: A dominant role of CCL2","volume":"96","author":"Schulz","year":"2011","journal-title":"Haematologica"},{"key":"ref_19","first-page":"e7090","article-title":"The Role of Blood Viscosity in Infectious Diseases","volume":"12","author":"Sloop","year":"2020","journal-title":"Cureus"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"7613","DOI":"10.1038\/srep07613","article-title":"Decreased deformability of lymphocytes in chronic lymphocytic leukemia","volume":"5","author":"Zheng","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1053\/j.seminoncol.2006.01.027","article-title":"Strategies in the Management of Alemtuzumab-Related Side Effects","volume":"33","author":"Karlsson","year":"2006","journal-title":"Semin. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/bmjqs-2015-004411","article-title":"SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): Revised publication guidelines from a detailed consensus process","volume":"25","author":"Ogrinc","year":"2016","journal-title":"BMJ Qual. Saf."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1002\/anie.200700613","article-title":"Covalently functionalized cobalt nanoparticles as a platform for magnetic separations in organic synthesis","volume":"46","author":"Grass","year":"2007","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12951-019-0506-y","article-title":"Biochemical functionality of magnetic particles as nanosensors: How far away are we to implement them into clinical practice?","volume":"17","author":"Doswald","year":"2019","journal-title":"J. Nanobiotechnol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/8\/7523\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:19:03Z","timestamp":1760123943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/8\/7523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,19]]},"references-count":24,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["ijms24087523"],"URL":"https:\/\/doi.org\/10.3390\/ijms24087523","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2023,4,19]]}}}